Search Results

The philanthropic gift creates a center to help accelerate translational research, recruit faculty and train the next generation of leaders in vision science.

An antibody to the cell receptor PD-1 may launch a two-pronged assault on cancer by initiating attacks by both T cells and macrophages, a Stanford study has found.

Juggling medical school and scientific research, Stanford students came together in a poster board competition to show the depth and breadth of their projects, from global health to stem cells.

Researchers at Stanford Medicine and the Gladstone Institutes will use the gift for gene editing and stem cell techniques to develop treatments for the neurodegenerative disorder.

Dominique Bergmann, John Pringle and Anne Villeneuve are now part of an organization designed to advise the nation on issues related to science and technology.

Stanford investigators fused two stem-cell-derived neural spheroids, each containing a different type of human neuron, then watched as one set of neurons migrated and hooked up with the other set.

Pretreatment with a stem-cell-activating protein significantly enhances healing in mice, Stanford researchers say. The approach could eventually help people going into surgery or combat heal better from injuries they sustain.

A common signaling pathway unites diverse fibrotic diseases in humans, Stanford researchers have found. An antibody called anti-CD47, which is being tested as an anti-cancer agent, reverses fibrosis in mice.

Neuroscientists’ discovery of grid cells, popularly known as the brain’s GPS, was hailed as a major discovery. But new Stanford research suggest the system is more complicated than anyone had guessed.

A regulatory protein actively blocks the expression of non-neuronal genes in nerve cells, according to new Stanford research. The finding suggests there are many master regulators to help cell types maintain their identities.